BLACKROCK SMALLER COMPANIES TRUST plc
All information is at 31 October 2010 and unaudited.
Performance at month end is calculated on a capital only basis
One Three One Three Five
Month Months Year Years Years
Net asset value 6.3% 23.9% 46.6% 9.6% 79.2%
Share price 6.5% 23.2% 51.4% 8.9% 75.1%
HGSC ex Inv Trust + AIM* 3.4% 11.9% 20.5% -15.9% 7.3%
Sources: BlackRock and Datastream
*With effect from 1 September 2007 the Hoare Govett Smaller Companies plus AIM
(ex Investment Companies) Index replaced the FTSE SmallCap Index (ex Investment
Companies) as the Company's benchmark. For the five year period the above index
has been blended to reflect this.
At month end
Net asset value Capital only (debt at par value): 525.43p
Net asset value Capital only (debt at fair value): 521.19p
Net asset value incl. Income (debt at par value): 530.20p**
Net asset value incl. Income (debt at fair value): 525.96p**
Share price: 428.50p
Discount to Capital only NAV (debt at par value): 18.4%
Discount to Capital only NAV (debt at fair value): 17.8%
Net yield: 1.4%
Total assets: £275.2m^
Gearing incl. Income: 8.5%
Ordinary shares in issue: 47,879,792^^
**includes net revenue of 4.77p.
^includes current year revenue.
^^excludes 2,113,731 shares held in treasury.
Ten Largest Sector
Weightings % of Total Assets
Industrial Metals & Mining 12.0
Software & Computer Services 10.0
Electronic & Electrical Equipment 9.0
Oil & Gas Producers 8.7
Financial Services 8.1
Support Services 7.5
Industrial Engineering 6.7
Media 5.6
Pharmaceuticals & Biotechnology 4.9
Technology Hardware & Equipment 4.4
----
Total 76.9
====
Ten Largest Equity Investments (in alphabetical order)
Company
Abcam Group
Aveva Group
City of London Investment Group
Domino Printing Sciences
Eastern Platinum
Fidessa group
Hutchison China Meditech
IQE
Spirax-Sarco Engineering
Western Coal
Commenting on the markets, Mike Prentis, representing the Investment Manager
noted:
During October the Company's NAV per share rose by 6.3% in capital only terms;
this was ahead of the benchmark which rose by 3.4%. The FTSE 100 Index rose by
2.3%. Our outperformance was mainly derived from stock selection but asset
allocation and gearing also contributed.
From a stock point of view, two holdings contributed more than 0.25% each to
relative outperformance, Hutchison China Meditech and City of London Investment
Group. Hutchison China Meditech had been our one poor performer in September,
although there had been no newsflow. October was also a month of no news for
the stock, but the share price did make up for its weak performance in
September. City of London Investment Group announced that assets under
management had increased 30% since its 31 May year end, helped by stronger
emerging markets indices. It also moved its listing from AIM to the Official
List. Pleasingly, no one holding had a significant negative impact on the
relative performance of the portfolio during the month.
We sold our holding in Bluebay Asset Management following a bid by Royal Bank
of Canada. Our holding in Bluebay had only been acquired in September, so we
were very surprised to see a bid emerge. We also sold our holding in Intec
Telecom which had received a bid from CSG of the US.
We took new holdings in TT Electronics and New Britain Palm Oil. TT Electronics
supplies sensors and other components mainly into automotive and industrial
markets globally. New management have reshaped the business and are driving up
margins from low levels. We feel the business is still undervalued
and it is trading well. New Britain Palm Oil is a significant producer of palm
oil based in the Pacific. We had no previous exposure to soft commodities and
with the palm oil price moving up sharply, as have many soft commodity prices,
we felt it appropriate to make a small investment.
Latest information is available by typing www.blackrock.co.uk/its on the
internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV
terminal).
15 November 2010
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.